Professor Peter Andrews

School of Biosciences

Emeritus Professor

p.w.andrews@sheffield.ac.uk
+44 114 222 4173
E, Alfred Denny Building

Full contact details

Professor Peter Andrews
School of Biosciences
E
Alfred Denny Building
Western Bank
Sheffield
S10 2TN
Profile

School of Biosciences (formerly the Department of Biomedical Science), the University of Sheffield

  • Arthur Jackson Professor of Biomedical Science: 1992-present
  • Chairman of Department 1995-2003

The Wistar Institute of Anatomy and Biology, Philadelphia

  • Associate Professor: 1991-1992
  • Assistant Professor: 1983-1990
  • Research Associate: 1980-1982
  • Research Investigator: 1978-1979

Sloan-Kettering Institute, New York

  • Research Fellow: 1976-1978

Institut Pasteur, Paris

  • Research Fellow: 1974-1975
Research interests

The Biology of human Embryonic Stem Cells and their Malignant counterparts from Teratocarcinomas.

The Biology of Human Pluripotent Stem Cell Fate Determinations

Human embryonic stem cells (HESCs) are derived from the inner cell mass of the early embryo; the cells are genetically normal and retain in vitro both the ability to self renew and also to differentiate into each of the cell types found in the adult body. Such a system offers an in vitro model of human embryogenesis. Thus, a powerful resource now exists for the investigation of human developmental biology, the testing of candidate drugs for toxicology and efficacy and ultimately, tissue engineering for regenerative medicine.

The sensitivity of HESCs to biologically active factors and their developmental plasticity are attributes that confer upon them such great potential, but also present significant obstacles to their exploitation.

Many of these issues derive from an inadequate understanding of how HESCs regulate their self renewal and commitment to differentiation, and how these processes may be affected by the environment in which the cells are maintained.

Adaptation of Human embryonic Stem Cells to in vitro culture

In human ES cells, after prolonged culture, repetitive karyotypic changes have been noted (1, 2). These repetitive karyotypic changes are strikingly similar to the karyotypic abnormalities observed in Embryonal Carcinoma (EC) cells, which are the malignant stem cells of germ cell tumours.

Culture adapted ES cells may also show higher proliferative and cloning ability than their `normal´ early passage counterparts. Pluripotent ES cells in culture are subject to continual selection for genetic variants that increase the probability of `self-renewal´ and decrease the probability of differentiation or apoptosis. It also seems likely that EC cells in germ cell tumours are subject to similar selection pressures. Thus understanding the nature of the karyotypic and other genetic changes that occur in human ES cells in culture may give insights, not only into the genetic and molecular mechanisms that control self-renewal and commitment in these cells, but also give insights into the processes of cancer development and progression in germ cell tumours.

Embryonal Carcinoma (EC) Cells and Germ Cell Tumours

EC cells are the malignant stem cells of teratocarcinomas, a subset of germ cell tumours which occur predominantly as testicular cancers and are the most common cancers of young men. (3). EC cells are malignant counterparts of ES cells derived from human blastocysts. Human EC cells share some features in common with mouse ES and EC cells (e.g. expression of the transcription factors Oct4 and Nanog, and high levels of alkaline phosphatase) but they differ in other respects such as their distinct patterns of surface marker antigen expression. Neverthelesss, just as mouse EC and ES cells resemble the inner cell mass cells of the early mouse embryo at the blastocyst stage, so human EC cells resemble human ES cells and inner cell mass cells of early human blastocysts (4).

Over many years we have used EC cell lines as surrogates for the study of plurotent human ES cells and have used them to define a series of marker antigens for defining the undifferentiated EC phenotype (5) and for monitoring differentiation (6). These antigens are now widely used in the study of human ES cells (7). Human EC cell lines also remain relatively simple models for further studies with ES cells, since they can readily be grown in large numbers without the need for feeder cells or expensive media additives. Widely used lines include relatively nullipotent lines such as 2102Ep, useful in defining the phenotype of undifferentiated human EC and ES cells, and NTERA2 which differentiates extensively into neurons and other cells types when induced by agents such as retinoic acid (8). Studies in NTERA2 provided the first evidence of the dosage dependence of retinoic acid induction of HOX gene expression, in a way that appears to reflect the pattern of HOX gene expression along the anterior posterior axis of the developing embryo (9). In a different area of research, differentiatial susceptibility of undifferentiated and differentiated NTERA2 EC cells to replication of human cytomegalovirus (HCMV) and human immunodeficiency virus (HIV) provides tools for investigating the interaction of these pathogenic viruses with human cells (10, 11).

Signalling pathways that contribute to the self-renewal and differentiation of human embryonic stem cells

Multiple signalling pathways contribute to maintenance of the undifferentiated state of ES cells and to controlling their commitment to differentiation. Relatively little is known about how specific pathways interact with each other in ES cells, but it is becoming evident that the relative importance of particular pathways may differ substantially between mouse and human ES cells. We are currently using a variety of approaches, including comparative studies of `normal´ and `adapted´ ES cells, as well as studies of human EC cells to identify particular signalling systems that contribute to self renewal and differentiation in human ES cells. Our specific areas of interest include the Notch and Wnt pathways as well as the role of TGFbeta superfamily members. Our techniques include the use of RNAi to modulate gene expression Using the latter technique , for exampole, we demomnstrated that, indeed, human EC and ES cells require the expression of Oct4 to maintain their undifferentiated state and that if its expression is knocked-down, differentiation towards trophectoderm ensues (12).

Differentiation of Human ES cells

Pluripotency of human ES cells is their property that offers such great potential for future applications. Human ES cells will spontaneously differentiate into a wide range of cell types but this process is difficult to control. Eventual applications will depend on understanding the mechanisms that control lineage selection once the cells commit to differentiate and developing protocols to make use of that knowledge. In our group we are specifically focussing on the mechanisms that regulate neural differentiation and differentiation toward pancreatic cells. Eventually these cell types could be used in regenerative medicine to treat a range of neurodegenerative diseases and diabetes. However, it is important to recognise that considerable research and development will be necessary before these goals can be realised.

The Centre for Stem Cell Biology

The Centre for Stem Cell Biology (CSCB), directed by Professors Peter W Andrews and Harry D Moore, brings together researchers in the University of Sheffield interested in the biology of human ES cells and in developing applications that involve these cells. Within the CSCB, we have derived six new human ES cell lines and are building a new cGMP facility that will enable us to derive new lines in the future to meet standards required for their future clinical applications. The CSCB also runs an annual training course in the culture of human ES cells, and can provide assistance to others who wish to establish human ES cell research in their own laboratories. For this we have specific funding from the MRC to operate a `Human ES Cell Resesource Centre´ to assist development of human ES cell research throughout the UK. As well as a variety of human ES cell lines, we also maintain various facilities such as a recently installed state-of-the-art Dakocytomation cell sorter.

The International Stem Cell Initiative (ISCI)

The ISCI is a study being carried out under the auspices of the International Stem Cell Forum. It includes a comparative study of surface antigen markers and gene expression patterns of up to 75 human ES cell lines from some 15 laboratories and 10 countries worldwide (13). It is expected to complete its work and issue a report by the end of 2005.

Publications

Show: Featured publications All publications

Journal articles

  • Thompson O, von Meyenn F, Hewitt Z, Alexander J, Wood A, Weightman R, Gregory S, Krueger F, Andrews S, Barbaric I , Gokhale PJ et al (2020) . Nature Communications, 11(1).
  • Allison TF, Smith AJH, Anastassiadis K, Sloane-Stanley J, Biga V, Stavish D, Hackland J, Sabri S, Langerman J, Jones M , Plath K et al (2018) . Stem Cell Reports, 10(6), 1895-1907.
  • Allison TF, Andrews PW, Avior Y, Barbaric I, Benvenisty N, Bock C, Brehm J, Bruestle O, Damjanov I, Elefanty A , Felkner D et al (2018) . Nature Communications, 9.
  • Hackland JOS, Frith TJR, Thompson O, Marin Navarro A, Garcia-Castro MI, Unger C & Andrews PW (2017) . Stem Cell Reports, 9(4), 1043-1052.
  • Andrews PW, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles BB, Nagy A, Pera M, Reubinoff B, Rugg-Gunn PJ & Stacey GN (2017) . Stem Cell Reports, 9(1), 1-4.
  • Baker D, Hirst AJ, Gokhale PJ, Juarez MA, Williams S, Wheeler M, Bean K, Allison TF, Moore HD, Andrews PW & Barbaric I (2016) . Stem Cell Reports, 7(5), 998-1012.
  • Burns AJ, Goldstein AM, Newgreen DF, Stamp L, Schäfer K-H, Metzger M, Hotta R, Young HM, Andrews PW, Thapar N , Belkind-Gerson J et al (2016) . Developmental Biology, 417(2), 229-251.
  • Damjanov I & Andrews PW (2016) . The International Journal of Developmental Biology, 60(10-11-12), 337-419.
  • Gokhale PJ, Au-Young JK, Dadi S, Keys DN, Harrison NJ, Jones M, Soneji S, Enver T, Sherlock JK & Andrews PW (2015) . PLoS ONE, 10(4).
  • Barbaric I, Biga V, Gokhale PJ, Jones M, Stavish D, Glen A, Coca D & Andrews PW (2014) . Stem Cell Reports, 3(1), 142--155.
  • Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P , Andrews PW et al (2013) . Stem Cell Reports, 1(5), 379-386.
  • Desmarais JA, Hoffmann MJ, Bingham G, Gagou ME, Meuth M & Andrews PW (2012) . Stem Cells, 30(7), 1385-1393.
  • International Stem Cell Initiative , Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB , Beil S et al (2011) . Nat Biotechnol, 29(12), 1132-1144.
  • Tonge PD, Shigeta M, Schroeder T & Andrews PW (2011) . Stem Cell Res, 7(2), 145-153.
  • Avery S, Zafarana G, Gokhale PJ & Andrews PW (2010) . Stem Cells, 28(5), 863-873.
  • Olariu V, Harrison NJ, Coca D, Gokhale PJ, Baker D, Billings S, Kadirkamanathan V & Andrews PW (2010) . Stem Cell Res, 4(1), 50-56.
  • Tonge PD, Olariu V, Coca D, Kadirkamanathan V, Burrell KE, Billings SA & Andrews PW (2010) . PLoS One, 5(5), e10901.
  • Enver T, Pera M, Peterson C & Andrews PW (2009) . CELL STEM CELL, 4(5), 387-397.
  • Zafarana G, Avery SR, Avery K, Moore HD & Andrews PW (2009) . Stem Cells, 27(4), 776-782.
  • Atlasi Y, Mowla SJ, Ziaee SAM, Gokhale PJ & Andrews PW (2008) . Stem Cells, 26(12), 3068-3074.
  • Vugler A, Lawrence J, Walsh J, Carr A, Gias C, Semo M, Ahmado A, da Cruz L, Andrews P & Coffey P (2007) . Mechanisms of Development, 124(11-12), 807-829.
  • Damjanov I & Andrews PW (2007) . NAT BIOTECHNOL, 25(11), 1212-1212.
  • International Stem Cell Initiative , Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS , Bevan S et al (2007) . Nat Biotechnol, 25(7), 803-816.
  • Frith TJR, Granata I, Stout E, Wind M, Thompson O, Neumann K, Stavish D, Heath PR, Hackland JOS, Anastassiadis K , Gouti M et al () .

Book chapters

  • Hackland JOS, Frith TJR & Andrews PW (2019) , Methods in Molecular Biology (pp. 49-54). Springer New York

All publications

Journal articles

  • Li S, Alexander J, Kendall J, Andrews P, Rose E, Orjuela H, Park S, Podszus C, Shanley L, Ranade N , Morris P et al (2025) . Genome Biology, 26(1), 314.
  • Mason JE, Nie X, Coca D & Andrews PW (2025) . Stem Cell Reports, 20(6), 102532-102532.
  • Boisen IM, Krarup Knudsen N, Nielsen JE, Kooij I, Bagger ML, Kaludjerovic J, O'Shaughnessy P, Andrews PW, Ide N, Toft BG , Juul A et al (2025) . eLife, 13.
  • Andrews PW (2024) . BioEssays, 46(12).
  • Andrews PW (2024) . BioEssays, e2400094.
  • Jevans B, Cooper F, Fatieieva Y, Gogolou A, Kang Y-N, Restuadi R, Moulding D, Vanden Berghe P, Adameyko I, Thapar N , Andrews PW et al (2024) . Gut.
  • Andrews PW & Gokhale PJ (2023) . Stem Cell Reports.
  • Ludwig TE, Andrews PW, Barbaric I, Benvenisty N, Bhattacharyya A, Crook JM, Daheron LM, Draper JS, Healy LE, Huch M , Inamdar MS et al (2023) . Stem Cell Reports, 18(9), 1744-1752.
  • Saldana-Guerrero IM, Montano-Gutierrez LF, Hafemeister C, Stavish D, Shaw LE, Fetahu IS, Wenninger-Weinzierl A, Sturtzel C, Souilhol C, Tarelli S , Shoeb MR et al (2023) . Cancer Research, 83(7_Supplement), 3542-3542.
  • Pridgeon CS, Forootan SS, Zhang F, Harper N, Palmer D, Weightmann R, Gregory S, Hewitt Z, Baker D, Halliwell J , Moore H et al (2023) In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells. JOURNAL OF STEM CELLS & REGENERATIVE MEDICINE, 19(1), P2-P12.
  • Andrews PW, Barbaric I, Benvenisty N, Draper JS, Ludwig T, Merkle FT, Sato Y, Spits C, Stacey GN, Wang H & Pera MF (2022) . Cell Stem Cell, 29(12), 1624-1636.
  • Abu-Dawud R, Mistry BV, Almahdali R, Matin MM, Alaiya A, Alghamdi F, Alamari H, Al-Yacoub N, Kashir J, Houssein M , Alawad A et al (2022) . Tissue and Cell, 101893-101893.
  • Andrews PW (2021) . Biomaterials Translational, 2(4), 294-300.
  • Halliwell J, Baker D, Judge K, Quail MA, Oliver K, Betteridge E, Skelton J, Andrews PW & Barbaric I (2021) . Stem Cells and Development.
  • Andrews PW (2021) . Regenerative Medicine, 16(2), 113-115.
  • Wind M, Gogolou A, Manipur I, Granata I, Butler L, Andrews PW, Barbaric I, Ning K, Guarracino MR, Placzek M & Tsakiridis A (2021) . Development, 148(6).
  • Thompson O, von Meyenn F, Hewitt Z, Alexander J, Wood A, Weightman R, Gregory S, Krueger F, Andrews S, Barbaric I , Gokhale PJ et al (2020) . Nature Communications, 11(1).
  • Halliwell J, Barbaric I & Andrews PW (2020) . Nature Reviews Molecular Cell Biology, 21(12), 715-728.
  • Stavish D, Böiers C, Price C, Frith TJR, Halliwell J, Saldaña-Guerrero I, Wray J, Brown J, Carr J, James C , Barbaric I et al (2020) . Nature Communications, 11.
  • Hoff AM, Kraggerud SM, Alagaratnam S, Berg KCG, Johannessen B, Høland M, Nilsen G, Lingjærde OC, Andrews PW, Lothe RA & Skotheim RI (2020) . Endocrine-Related Cancer, 27(9), 457-468.
  • Frith TJR, Gogolou A, Hackland JOS, Hewitt ZA, Moore HD, Barbaric I, Thapar N, Burns AJ, Andrews PW, Tsakiridis A & McCann CJ (2020) . Stem Cell Reports.
  • Halliwell JA, Frith TJR, Laing O, Price CJ, Bower OJ, Stavish D, Gokhale PJ, Hewitt Z, El-Khamisy SF, Barbaric I & Andrews PW (2020) . Stem Cell Reports, 14(6), 1009-1017.
  • Zhang J, Hirst AJ, Duan F, Qiu H, Huang R, Ji Y, Bai L, Zhang F, Robinson D, Jones M , Li L et al (2019) . Stem Cell Reports, 12(3), 557-571.
  • Stacey GN, Andrews P, Barbaric I, Boiers C, Chandra A, Cossu G, Csontos L, Frith TJR, Halliwell JA, Hewitt Z , McCall M et al (2019) . Regenerative medicine, 14(3), 243-255.
  • Stacey G, Andrews P, Asante C, Barbaric I, Barry J, Bisset L, Braybrook J, Buckle R, Chandra A, Coffey P , Crouch S et al (2018) . Regenerative Medicine, 13(8), 935-944.
  • Allison TF, Smith AJH, Anastassiadis K, Sloane-Stanley J, Biga V, Stavish D, Hackland J, Sabri S, Langerman J, Jones M , Plath K et al (2018) . Stem Cell Reports, 10(6), 1895-1907.
  • Allison TF, Andrews PW, Avior Y, Barbaric I, Benvenisty N, Bock C, Brehm J, Bruestle O, Damjanov I, Elefanty A , Felkner D et al (2018) . Nature Communications, 9.
  • Kyriakides O, Halliwell JA & Andrews PW (2017) . Advances in Biochemical Engineering Biotechnology.
  • Hackland JOS, Frith TJR, Thompson O, Marin Navarro A, Garcia-Castro MI, Unger C & Andrews PW (2017) . Stem Cell Reports, 9(4), 1043-1052.
  • Andrews PW, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles BB, Nagy A, Pera M, Reubinoff B, Rugg-Gunn PJ & Stacey GN (2017) . Stem Cell Reports, 9(1), 1-4.
  • Baker D, Hirst AJ, Gokhale PJ, Juarez MA, Williams S, Wheeler M, Bean K, Allison TF, Moore HD, Andrews PW & Barbaric I (2016) . Stem Cell Reports, 7(5), 998-1012.
  • Burns AJ, Goldstein AM, Newgreen DF, Stamp L, Schäfer K-H, Metzger M, Hotta R, Young HM, Andrews PW, Thapar N , Belkind-Gerson J et al (2016) . Developmental Biology, 417(2), 229-251.
  • Damjanov I & Andrews PW (2016) . The International Journal of Developmental Biology, 60(10-11-12), 337-419.
  • Andrews PW & Elvassore N (2016) . Biochemical and Biophysical Research Communications, 473(3), 663-664.
  • Desmarais JA, Unger C, Damjanov I, Meuth M & Andrews P (2016) . Stem Cell Research and Therapy, 7(1), 17-17.
  • Damjanov I & Andrews PW (2016) . International Journal of Developmental Biology, 60(10-12), 321-325.
  • Hoff AM, Alagaratnam S, Zhao S, Bruun J, Andrews PW, Lothe RA & Skotheim RI (2016) . American Journal of Cancer, 76(1), 108-116.
  • Jones AJ, Gokhale PJ, Allison TF, Sampson B, Athwal S, Grant S, Andrews PW, Allen ND & Patrick Case C (2015) . Scientific Reports, 5(1).
  • Gokhale PJ, Au-Young JK, Dadi S, Keys DN, Harrison NJ, Jones M, Soneji S, Enver T, Sherlock JK & Andrews PW (2015) . PLoS ONE, 10(4).
  • Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi Y-M, Crook JM, de Sousa PA , Dvorak P et al (2015) . Regenerative Medicine, 10(2s), 1-44.
  • Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, Baty R, Graziano EI, Proto Marco B, Caron A , Sköld P et al (2015) . STEM CELLS Translational Medicine, 4(4), 389-400.
  • Heslop JA, Hammond TG, Santeramo I, Piella AT, Hopp I, Zhou J, Baty R, Graziano EI, Marco BP, Caron A , Sköld P et al (2015) . Stem Cells Translational Medicine, 4(4), 389-400.
  • Ben-David U, Arad G, Weissbein U, Mandefro B, Maimon A, Golan-Lev T, Narwani K, Clark AT, Andrews PW, Benvenisty N & Carlos Biancotti J (2014) . Nature Communications, 5(1).
  • Sutiwisesak R, Kitiyanant N, Kotchabhakdi N, Felsenfeld G, Andrews PW & Wongtrakoongate P (2014) . Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843(11), 2611-2619.
  • Andrews PW, Cavagnaro J, Deans R, Feigal E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I & Yamanaka S (2014) . Nature Biotechnology, 32(8), 724-726.
  • Na J, Baker D, Zhang J, Andrews PW & Barbaric I (2014) . Protein Cell, 5(8), 569-579.
  • Barbaric I, Biga V, Gokhale PJ, Jones M, Stavish D, Glen A, Coca D & Andrews PW (2014) . Stem Cell Reports, 3(1), 142--155.
  • Allison T, Powles-Glover NS, Stewart J & Andrews PW (2014) A Novel Human Embryoid Body System (hEB) with Potential to Be Used for Screening Drug Candidates in the Field of Reproductive Toxicology. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 100(5), 405-405.
  • Isasi R, Andrews PW, Baltz JM, Bredenoord AL, Burton P, Chiu I-M, Hull SC, Jung J-W, Kurtz A, Lomax G , Ludwig T et al (2014) . Cell Stem Cell, 14(4), 427-430.
  • Wongtrakoongate P, Li J & Andrews PW (2014) . British Journal of Cancer.
  • Andrews PW, Cavanagro J, Deans R, Feigel E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I & Yamanaka S (2014) . Nature Biotechnology, 32(11), 1166-1166.
  • Wongtrakoongate P, Li J & Andrews PW (2014) . Exp Cell Res, 321(2), 231-239.
  • Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P , Andrews PW et al (2013) . Stem Cell Reports, 1(5), 379-386.
  • Gokhale PJ & Andrews PW (2013) . Neuroreport, 24(18), 1031-1034.
  • Kong L, Aho KL, Granberg K, Lund R, Järvenpää L, Seppälä J, Gokhale P, Leinonen K, Hahne L, Mäkelä J , Laurila K et al (2013) . Nature Methods, 10(9), 814-815.
  • Lund RJ, Emani MR, Barbaric I, Kivinen V, Jones M, Baker D, Gokhale P, Nykter M, Lahesmaa R & Andrews PW (2013) . Stem Cell Res, 11(3), 1022-1036.
  • Alagaratnam S, Harrison N, Bakken AC, Hoff AM, Jones M, Sveen A, Moore HD, Andrews PW, Lothe RA & Skotheim RI (2013) . Stem Cells and Development, 22(7), 1136-1146.
  • Draper JS & Andrews PW (2013) , 1, 375-382.
  • Johnson P & Andrews PW (2013) , 1, 89-94.
  • Wongtrakoongate P, Jones M, Gokhale PJ & Andrews PW (2013) . PLoS One, 8(2), e56893.
  • Lund RJ, Nikula T, Rahkonen N, Närvä E, Baker D, Harrison N, Andrews P, Otonkoski T & Lahesmaa R (2012) . Stem Cell Research, 9(3), 192-195.
  • Chen W, Jongkamonwiwat N, Abbas L, Eshtan SJ, Johnson SL, Kuhn S, Milo M, Thurlow JK, Andrews PW, Marcotti W , Moore HD et al (2012) . Nature, 490(7419), 278-282.
  • Gokhale PJ & Andrews PW (2012) . Curr Opin Genet Dev, 22(5), 403-408.
  • Hyka-Nouspikel N, Desmarais J, Gokhale PJ, Jones M, Meuth M, Andrews PW & Nouspikel T (2012) . Stem Cells, 30(9), 1901-1910.
  • Desmarais JA, Hoffmann MJ, Bingham G, Gagou ME, Meuth M & Andrews PW (2012) . Stem Cells, 30(7), 1385-1393.
  • Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C , Sipp D et al (2012) . Regenerative Medicine, 7(3), 439-448.
  • International Stem Cell Initiative , Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB , Beil S et al (2011) . Nat Biotechnol, 29(12), 1132-1144.
  • Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, Keehan R, Grummer R, Winterhager E, Gokhale PJ , Andrews PW et al (2011) . Nat Nanotechnol, 6(12), 824-833.
  • Barbaric I, Jones M, Buchner K, Baker D, Andrews PW & Moore HD (2011) . Cryobiology, 63(3), 298-305.
  • Tonge PD, Shigeta M, Schroeder T & Andrews PW (2011) . Stem Cell Res, 7(2), 145-153.
  • Goldring CEP, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR , Kurth J et al (2011) . Cell Stem Cell, 9(2), 176-176.
  • Wright A, Andrews N, Bardsley K, Nielsen JE, Avery K, Pewsey E, Jones M, Harley D, Nielsen AR, Moore H , Gokhale P et al (2011) . Int J Androl, 34(4 Pt 2), e175-e187.
  • Barbaric I, Jones M, Harley DJ, Gokhale PJ & Andrews PW (2011) . J Biomol Screen, 16(6), 603-617.
  • Barbaric I, Jones M, Buchner K, Baker D, Andrews PW & Moore HD (2011) . Cryobiology, 63(3), 298-305.
  • Goldring CEP, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR , Kurth J et al (2011) . Cell Stem Cell, 8(6), 618-628.
  • Andrews PW (2011) . Nat Biotechnol, 29(9), 803-805.
  • Fazeli A, Liew C-G, Matin MM, Elliott S, Jeanmeure LFC, Wright PC, Moore H & Andrews PW (2011) . Int J Dev Biol, 55(2), 175-180.
  • Na J, Plews J, Li J, Wongtrakoongate P, Tuuri T, Feki A, Andrews PW & Unger C (2010) . Stem Cell Research and Therapy, 1(4).
  • Calvanese V, Lara E, Suarez-Alvarez B, Abu Dawud R, Vazquez-Chantada M, Martinez-Chantar ML, Embade N, Lopez-Nieva P, Horrillo A, Hmadcha A , Soria B et al (2010) . P NATL ACAD SCI USA, 107(31), 13736-13741.
  • Barbaric I, Gokhale PJ & Andrews PW (2010) . Biochem Soc Trans, 38(4), 1046-1050.
  • Na J, Furue MK & Andrews PW (2010) . Stem Cell Res, 5(2), 157-169.
  • Tonge PD & Andrews PW (2010) . Differentiation, 80(1), 20-30.
  • Pewsey E, Bruce C, Tonge P, Evans C, Ow SY, Georgiou AS, Wright PC, Andrews PW & Fazeli A (2010) . J Proteome Res, 9(7), 3412-3426.
  • Barbaric I, Gokhale PJ, Jones M, Glen A, Baker D & Andrews PW (2010) . Stem Cell Res, 5(2), 104-119.
  • Hovatta O, Jaconi M, Tohonen V, Bena F, Gimelli S, Bosman A, Holm F, Wyder S, Zdobnov EM, Irion O , Andrews PW et al (2010) . PLOS ONE, 5(4).
  • Aflatoonian B, Ruban L, Shamsuddin S, Baker D, Andrews P & Moore H (2010) . In Vitro Cellular & Developmental Biology - Animal, 46(3-4), 236-241.
  • Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P , Hovatta O et al (2010) . Nat Biotechnol, 28(4), 371-377.
  • International Stem Cell Initiative Consortium , Akopian V, Andrews PW, Beil S, Benvenisty N, Brehm J, Christie M, Ford A, Fox V, Gokhale PJ , Healy L et al (2010) . In Vitro Cell Dev Biol Anim, 46(3-4), 247-258.
  • Andrews PW, Benvenisty N, Knowles BB, McKay RDG, Oh SKW, Pera MF, Rossant J & Stacey GN (2010) . In Vitro Cell Dev Biol Anim, 46(3-4), 167-168.
  • Avery S, Zafarana G, Gokhale PJ & Andrews PW (2010) . Stem Cells, 28(5), 863-873.
  • Plews JR, Li J, Jones M, Moore HD, Mason C, Andrews PW & Na J (2010) . PLoS One, 5(12), e14397.
  • Olariu V, Harrison NJ, Coca D, Gokhale PJ, Baker D, Billings S, Kadirkamanathan V & Andrews PW (2010) . Stem Cell Res, 4(1), 50-56.
  • Avery S, Zafarana G, Gokhale PJ & Andrews PW (2010) The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells, 28(6), 863-873.
  • Tonge PD, Olariu V, Coca D, Kadirkamanathan V, Burrell KE, Billings SA & Andrews PW (2010) . PLoS One, 5(5), e10901.
  • Draper JS & Andrews PW (2009) , 423-428.
  • Johnson P & Andrews PW (2009) , 105-110.
  • Andrews PW, Arias-Diaz J, Auerbach J, Alvarez M, Ahrlund-Richter L, Baker D, Benvenisty N, Ben-Josef D, Blin G, Borghese L , Borstlap J et al (2009) . STEM CELL REV REP, 5(4), 301-314.
  • Olariu V, Coca D, Billings SA, Tonge P, Gokhale P, Andrews PW & Kadirkamanathan V (2009) . Bioinformatics, 25(21), 2824-2830.
  • Andrews PW (2009) . STEM CELLS DEV, 18(8), 1113-1114.
  • Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, Harrison NJ, Schwager C, Abdollahi A, Huber PE , Brunak S et al (2009) . CANCER RES, 69(12), 5241-5250.
  • Enver T, Pera M, Peterson C & Andrews PW (2009) . CELL STEM CELL, 4(5), 387-397.
  • Harrison NJ, Barnes J, Jones M, Baker D, Gokhale PJ & Andrews PW (2009) . Stem Cells, 27(5), 1057-1065.
  • Chen W, Johnson SL, Marcotti W, Andrews PW, Moore HD & Rivolta MN (2009) . Stem Cells, 27(5), 1196-1204.
  • Wright AJ & Andrews PW (2009) . Stem Cell Res, 3(1), 3-11.
  • Zafarana G, Avery SR, Avery K, Moore HD & Andrews PW (2009) . Stem Cells, 27(4), 776-782.
  • Gokhale PJ & Andrews PW (2009) . Lab Invest, 89(3), 259-262.
  • Andrews PW & Gokhale PJ (2008) , 136-147.
  • Atlasi Y, Mowla SJ, Ziaee SAM, Gokhale PJ & Andrews PW (2008) . Stem Cells, 26(12), 3068-3074.
  • Calvanese V, Horrillo A, Hmadcha A, Suarez-Alvarez B, Fernandez AF, Lara E, Casado S, Menendez P, Bueno C, Garcia-Castro J , Rubio R et al (2008) . PLOS ONE, 3(9).
  • Furue MK, Na J, Jackson JP, Okamoto T, Jones M, Baker D, Hatal RI, Moore HD, Sato JD & Andrews PW (2008) . P NATL ACAD SCI USA, 105(36), 13409-13414.
  • Liew C-G, Draper JS, Walsh J, Moore H & Andrews PW (2008) . Stem Cells, 26(4), 1094-1094.
  • Fox V, Gokhale PJ, Walsh JR, Matin M, Jones M & Andrews PW (2008) . Stem Cells, 26(3), 715-723.
  • Gokhale PJ & Andrews PW (2008) . Cell Stem Cell, 2(1), 4-5.
  • Vugler A, Carr A-J, Lawrence J, Chen LL, Burrell K, Wright A, Lundh P, Semo M, Ahmado A, Gias C , da Cruz L et al (2008) . Experimental Neurology, 214(2), 347-361.
  • Liew CG & Andrews PW (2008) . Review of Diabetic Studies, 5(4), 203-219.
  • Liew CG, Shah NN, Briston SJ, Shepherd RM, Khoo CP, Dunne MJ, Moore HD, Cosgrove KE & Andrews PW (2008) . PLoS One, 3(3), e1783.
  • Vugler A, Lawrence J, Walsh J, Carr A, Gias C, Semo M, Ahmado A, da Cruz L, Andrews P & Coffey P (2007) . Mechanisms of Development, 124(11-12), 807-829.
  • Damjanov I & Andrews PW (2007) . NAT BIOTECHNOL, 25(11), 1212-1212.
  • Harrison NJ, Baker D & Andrews PW (2007) . Int J Androl, 30(4), 275-281.
  • International Stem Cell Initiative , Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS , Bevan S et al (2007) . Nat Biotechnol, 25(7), 803-816.
  • Draper JS, Séguin CA & Andrews PW (2007) , 91-106.
  • Liew C-G, Draper JS, Walsh J, Moore H & Andrews PW (2007) . Stem Cells, 25(6), 1521-1528.
  • Allegrucci C, Wu YZ, Thurston A, Denning CN, Priddle H, Mummery CL, Ward-van Oostwaard D, Andrews PW, Stojkovic M, Smith N , Parkin T et al (2007) . HUM MOL GENET, 16(10), 1253-1268.
  • Park H, Váradi A, Seok H, Jo J, Gilpin H, Liew CG, Jung S, Andrews PW, Molnár E & Cho K (2007) . Neuropharmacology, 52(6), 1403-1414.
  • Josephson R, Ording CJ, Liu Y, Shin S, Lakshmipathy U, Toumadje A, Love B, Chesnut JD, Andrews PW, Rao MS & Auerbach JM (2007) . STEM CELLS, 25(2), 437-446.
  • Baker DEC, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ, Heath PR, Holden H & Andrews PW (2007) . Nat Biotechnol, 25(2), 207-215.
  • Jackson JP, Tonge PD & Andrews PW (2007) , 61-91.
  • Chapman H, Piggot C, Andrews PW & Wann KT (2007) . BRAIN RES, 1129(1), 15-25.
  • Gokhale PJ & Andrews PW (2006) . Semin Reprod Med, 24(5), 289-297.
  • Harun R, Ruban L, Matin M, Draper J, Jenkins NM, Liew GC, Andrews PW, Li TC, Laird SM & Moore HDM (2006) . Hum Reprod, 21(6), 1349-1358.
  • Andrews PW (2006) . NAT BIOTECHNOL, 24(3), 325-326.
  • Adamah DJB, Gokhale PJ, Eastwood DJ, Rajpert De-Meyts E, Goepel J, Walsh JR, Moore HD & Andrews PW (2006) . Int J Androl, 29(1), 219-227.
  • Andrews PW (2006) , 1, 183-190.
  • Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, Monni O, Kallioniemi O & Lothe RA (2006) Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. CELL ONCOL, 28(5-6), 315-326.
  • Andrews PW (2005) . Journal of Anatomy, 207(6), 823-824.
  • Andrews PW, Matin MM, Bahrami AR, Damjanov I, Gokhale P & Draper JS (2005) . Biochem Soc Trans, 33(Pt 6), 1526-1530.
  • Liew C, Moore H, Ruban L, Shah N, Cosgrove K, Dunne M & Andrews P (2005) . Annals of Medicine, 37(7), 521-532.
  • Enver T, Soneji S, Joshi C, Brown J, Iborra F, Orntoft T, Thykjaer T, Maltby E, Smith K, Abu Dawud R , Jones M et al (2005) . HUM MOL GENET, 14(21), 3129-3140.
  • Andrews PW, Matin MM, Bahrami AR, Damjanov I, Gokhale P & Draper JS (2005) . Biochemical Society Transactions, 33(6), 1526-1530.
  • Andrews PW & Benvenisty N (2005) . CURR OPIN BIOTECH, 16(5), 485-486.
  • Bahrami AR, Matin MM & Andrews PW (2005) . Mech Dev, 122(9), 1034-1042.
  • Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, Duale N, Brunborg G, Kallioniemi I, Andrews PW & Lothe RA (2005) Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. CANCER RES, 65(13), 5588-5598.
  • Andrews PW, Benvenisty N, McKay R, Pera MF, Rossant J, Semb H, Stacey GN & Steering Committee of the International Stem Cell Initiative (2005) . Nat Biotechnol, 23(7), 795-797.
  • Draper JS, Moore HD, Ruban LN, Gokhale PJ & Andrews PW (2004) . Stem Cells Dev, 13(4), 325-336.
  • Andrews PW (2004) . Nature Biotechnology, 22(4), 382-382.
  • Daheron L, Opitz SL, Zaehres H, Lensch WM, Andrews PW, Itskovitz-Eldor J & Daley GQ (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. STEM CELLS, 22(5), 770-778.
  • Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, Moore HD & Andrews PW (2004) . Stem Cells, 22(5), 659-668.
  • Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson JA & Andrews PW (2004) . Nat Biotechnol, 22(1), 53-54.
  • Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO & Thomson JA (2003) . P NATL ACAD SCI USA, 100(23), 13350-13355.
  • Flasza M, Shering AF, Smith K, Andrews PW, Talley P & Johnson PA (2003) Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers. CLONING STEM CELLS, 5(4), 339-354.
  • Walsh J & Andrews PW (2003) . APMIS, 111(1), 197-210.
  • Draper JS & Andrews PW (2002) . Curr Opin Obstet Gynecol, 14(3), 309-315.
  • Matin MM, Andrews PW & Hornby DP (2002) . Anal Biochem, 304(1), 47-54.
  • Andrews PW (2002) . Philos Trans R Soc Lond B Biol Sci, 357(1420), 405-417.
  • Andrews PW, Moore H & Smith A (2002) Human embryonic stem cells: prospects for human health - a 1-day international symposium held at the University of Sheffield. J ANAT, 200(3), 221-223.
  • Draper JS, Pigott C, Thomson JA & Andrews PW (2002) . J Anat, 200(Pt 3), 249-258.
  • Gribaldo L, Alison M, Andrews PW, Bremer S, Donovan PJ, Knaän-Shanzer S, Mertelsmann R, Spielmann H, Testa NG, Triffitt JT , Zipori D et al (2002) . Experimental Hematology, 30(7), 628-633.
  • Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H & Andrews PW (2002) . Stem Cells, 20(4), 329-337.
  • Duran C, Talley PJ, Walsh J, Pigott C, Morton IE & Andrews PW (2001) . Int J Cancer, 93(3), 324-332.
  • Przyborski SA, Morton IE, Wood A & Andrews PW (2000) . Eur J Neurosci, 12(10), 3521-3528.
  • Gokhale PJ, Giesberts AM & Andrews PW (2000) Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation.. Cell Growth Differ, 11(3), 157-162.
  • Badcock G, Pigott C, Goepel J & Andrews PW (1999) The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.. Cancer Res, 59(18), 4715-4719.
  • Giesberts AN, Duran C, Morton IN, Pigott C, White SJ & Andrews PW (1999) . Mech Dev, 83(1-2), 115-125.
  • Wakeman JA, Walsh J & Andrews PW (1998) . Oncogene, 17(2), 179-186.
  • Andrews PW (1998) . APMIS, 106(1), 158-167.
  • Wakeman JA, Heath PR, Pearson RC & Andrews PW (1997) . Differentiation, 62(2), 97-105.
  • Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J, von Keitz A, Looijenga LH, Millán JL, Oosterhuis JW , Pera M et al (1996) . Int J Cancer, 66(6), 806-816.
  • Squires PE, Wakeman JA, Chapman H, Kumpf S, Fidock MD, Andrews PW & Dunne MJ (1996) . Eur J Neurosci, 8(4), 783-793.
  • Damjanov I, Zhu ZM, Andrews PW & Fenderson BA (1994) Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm. In Vivo, 8(6), 967-973.
  • ACKERMAN SL, KNOWLES BB & ANDREWS PW (1994) GENE-REGULATION DURING NEURONAL AND NONNEURONAL DIFFERENTIATION OF NTERA2 HUMAN TERATOCARCINOMA-DERIVED STEM-CELLS. MOL BRAIN RES, 25(1-2), 157-162.
  • WENK J, ANDREWS PW, CASPER J, HATA JI, PERA MF, VONKEITZ A, DAMJANOV I & FENDERSON BA (1994) GLYCOLIPIDS OF GERM-CELL TUMORS - EXTENDED GLOBE-SERIES GLYCOLIPIDS ARE A HALLMARK OF HUMAN EMBRYONAL CARCINOMA-CELLS. INT J CANCER, 58(1), 108-115.
  • SQUIRES PE, CHAPMAN HM & ANDREWS PW (1994) DEVELOPMENTAL REGULATION OF INTRACELLULAR CA2+ SIGNALS DURING THE NEURONAL DIFFERENTIATION OF NTERA2 HUMAN EMBRYONAL CARCINOMA-CELLS. J PHYSIOL-LONDON, 477P, P87-P87.
  • Rideg K, Hirka G, Prakash K, Bushar LM, Nothias J-Y, Weinmann R, Andrews PW & Gonczol E (1994) . Differentiation, 56(1-2), 119-129.
  • Andrews PW, Damjanov I, Berends J, Kumpf S, Zappavigna V, Mavilio F & Sampath K (1994) Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Laboratory Investigation, 71(2), 243-251.
  • GIWERCMAN A, ANDREWS PW, JORGENSEN N, MULLER J, GROEM N & SKAKKEBOEK NE (1993) IMMUNOHISTOCHEMICAL EXPRESSION OF EMBRYONAL MARKER TRA-1-60 IN CARCINOMA IN-SITU AND GERM-CELL TUMORS OF THE TESTIS. CANCER, 72(4), 1308-1314.
  • Fenderson BA, Radin N & Andrews PW (1993) . European Urology, 23(1), 30-37.
  • Zeichner SL, Hirka G, Andrews PW & Alwine JC (1992) . Journal of Virology, 66(4), 2268-2273.
  • Fenderson BA & Andrews PW (1992) . APMIS, 100(27 S), 109-118.
  • Bottero L, Simeone A, Arcioni L, Acampora D, Andrews PW, Boncinelli E & Mavilio F (1991) , 133-143.
  • Andrews PW, Marrink J, Hirka G, von Keitz A, Sleijfer DT & Gönczöl E (1991) , 63-83.
  • Marrink J, Andrews PW, Van Brummen PJ, De Jong HJ, Sleijfer DTH, Schraffordt Koops H & Oosterhuis JW (1991) . International Journal of Cancer, 49(3), 368-372.
  • Hirka G, Prakash K, Kawashima H, Plotkin SA, Andrews PW & Gönczöl E (1991) . Journal of Virology, 65(5), 2732-2735.
  • Andrews PW & Oliver RTD (1990) Introduction: Germ cell tumours of the testis. Cancer Surveys, 9(2), 239-241.
  • Simeone A, Acampora D, Arcioni L, Andrews PW, Boncinelli E & Mavilio F (1990) . Nature, 346(6286), 763-766.
  • Andrews PW, Nudelman E, Hakomori S-I & Fenderson BA (1990) . Differentiation, 43(2), 131-138.
  • Chen C, Fenderson BA, Andrews PW & Hakomori S (1989) . Biochemistry, 28(5), 2229-2238.
  • Andrews PW, Gönczöl E, Fenderson BA, Holmes EH, O'Malley G, Hakomori S & Plotkin S (1989) . The Journal of Experimental Medicine, 169(4), 1347-1359.
  • Rendt J, Erulkar S & Andrews PW (1989) . Experimental Cell Research, 180(2), 580-584.
  • Andrews PW (1988) . Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 948(1), 17-36.
  • Williams BP, Daniels GL, Pym B, Sheer D, Povey S, Okubo Y, Andrews PW & Goodfellow PN (1988) . Immunogenetics, 27(5), 322-329.
  • Mavilio F, Simeone A, Boncinelli E & Andrews PW (1988) . Differentiation, 37(1), 73-79.
  • Andrews PW (1987) . Journal of Cellular Biochemistry, 35(4), 321-332.
  • Andrews PW & Perussia B (1987) Induction of class i major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection. Cancer Research, 47(3), 740-746.
  • Fenderson BA, Andrews PW, Nudelman E, Clausen H & Hakomori S-I (1987) . Developmental Biology, 122(1), 21-34.
  • ANDREWS PW, FENDERSON B & HAKOMORI S-I (1987) . International Journal of Andrology, 10(1), 95-104.
  • SWALLOW DM, POVEY S, PARKAR M, ANDREWS PW, HARRIS H, PYM B & GOODFELLOW P (1986) . Annals of Human Genetics, 50(3), 229-235.
  • Tippett P, Andrews PW, Knowles BB, Solter D & Goodfellow PN (1986) . Vox Sanguinis, 51(1), 53-56.
  • Andrews PW, Gönczöl E, Plotkin SA, Dignazio M & Oosterhuis JW (1986) . Differentiation, 31(2), 119-126.
  • Lee VM & Andrews PW (1986) . The Journal of Neuroscience, 6(2), 514-521.
  • Andrews PW, Damjanov I, Simon D & Dignazio M (1985) . Differentiation, 29(2), 127-135.
  • DAMJANOV I, CLARK RK & ANDREWS PW (1985) . Annals of the New York Academy of Sciences, 455(1 Intermediate), 732-733.
  • ANDREWS PW, KNOWLES BB, PARKAR M, PYM B, STANLEY K & GOODFELLOW PN (1985) . Annals of Human Genetics, 49(1), 31-39.
  • Gonczol E, Andrews PW & Plotkin SA (1985) . Journal of General Virology, 66(3), 509-515.
  • Carlin CR & Andrews PW (1985) . Experimental Cell Research, 159(1), 17-26.
  • Gonczol E, Andrews P & Plotkin S (1984) . Science, 224(4645), 159-161.
  • ANDREWS PW, BANTING G, DAMJANOV I, ARNAUD D & AVNER P (1984) . Hybridoma, 3(4), 347-361.
  • Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC & Føgh J (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Laboratory Investigation, 50(2), 147-162.
  • Blaineau C, Connan F, Arnaud D, Andrews P, Williams L, McIlhinney J & Avner P (1984) . International Journal of Cancer, 34(4), 487-494.
  • Andrews PW (1984) . Developmental Biology, 103(2), 285-293.
  • ANDREWS PW, MEYER LJ, BEDNARZ KL & HARRIS H (1984) . Hybridoma, 3(1), 33-39.
  • Oosterhuis JW, Andrews PW, Knowles BB & Damjanov I (1984) . International Journal of Cancer, 34(1), 133-139.
  • Damjanov I, Clark RK & Andrews PW (1984) . Cell Differentiation, 15(2-4), 133-139.
  • Goodfellow PN & Andrews PW (1983) . Nature, 302(5910), 657-658.
  • Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB & Solter D (1983) . The EMBO Journal, 2(12), 2355-2361.
  • Tunnacliffe A, Goodfellow P, Banting G, Solomon E, Knowles BB & Andrews P (1983) . Somatic Cell Genetics, 9(5), 629-642.
  • Cossu G, Andrews PW & Warren L (1983) . Biochemical and Biophysical Research Communications, 111(3), 952-957.
  • Damjanov I (1983) Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro. Cancer Research, 43(5), 2190-2198.
  • Matthaei KI, Andrews PW & Bronson DL (1983) . Experimental Cell Research, 143(2), 471-474.
  • Andrews PW & Goodfellow PN (1982) . Nature, 299(5881), 296-297.
  • Goodfellow PN & Andrews PW (1982) . Nature, 295(5844), 11-13.
  • Andrews PW (1982) . International Journal of Cancer, 30(5), 567-571.
  • Goodfellow PN & Andrews PW (1982) . Nature, 300(5888), 107-108.
  • Andrews PW, Goodfellow PN, Shevinsky LH, Bronson DL & Knowles BB (1982) . International Journal of Cancer, 29(5), 523-531.
  • Andrews PW, Knowles BB & Goodfellow PN (1981) . Somatic Cell Genetics, 7(4), 435-443.
  • Benham FJ, Andrews PW, Knowles BB, Bronson DL & Harris H (1981) . Developmental Biology, 88(2), 279-287.
  • Andrews PW, Bronson DL, Benham F, Strickland S & Knowles BB (1980) . International Journal of Cancer, 26(3), 269-280.
  • Bronsor DL, Lange PH, Fraley EE, Cervenka J, Andrews PW & Solter D (1980) Cell line derived from a metastasis of a human testicular germ cell tumor. Cancer Research, 40(7), 2500-2506.
  • Andrews PW & Goodfellow PN (1980) . Somatic Cell Genetics, 6(2), 271-284.
  • Saldana-Guerrero IM, Montano-Gutierrez LF, Boswell K, Hafemeister C, Poon E, Shaw LE, Stavish D, Lea RA, Wernig-Zorc S, Bozsaky E , Fetahu IS et al () . Nature Communications, 15(1).
  • Andrews PW () . In Vitro Cellular & Developmental Biology - Animal.
  • () . Journal of Stem Cells and Regenerative Medicine.
  • Frith TJR, Granata I, Stout E, Wind M, Thompson O, Neumann K, Stavish D, Heath PR, Hackland JOS, Anastassiadis K , Gouti M et al () .
  • Barbaric I, Allison T, Powles-Glover N, Biga V & Andrews P () . International Journal of High Throughput Screening, 1-1.
  • Andrews PW, Bronson DL, Wiles MV & Goodfellow PN () . Tissue Antigens, 17(5), 493-500.

Book chapters

  • Hackland JOS, Frith TJR & Andrews PW (2019) , Methods in Molecular Biology (pp. 49-54). Springer New York
  • Draper JS & Andrews PW (2013) , Handbook of Stem Cells (pp. 375-382). Elsevier
  • Johnson P & Andrews PW (2013) , Handbook of Stem Cells (pp. 89-94). Elsevier
  • Addis RC, Ahlstrom JD, Amit M, Andrews PW, Axelman J, Surani MA, Benvenisty N, Bhatia M, Brivanlou AH, Carnwath JW , Carpenter MK et al (2013) , Handbook of Stem Cells (pp. xiii-xv). Elsevier
  • Harrison NJ, Baker D & Andrews PW (2012) , Advances in Stem Cell Research (pp. 17-27). Humana Press
  • Harrison NJ, Baker D & Andrews PW (2011) , Nuclear Reprogramming and Stem Cells (pp. 265-276). Humana Press
  • Andrews PW (2011) , Translational Stem Cell Research (pp. 35-43). Humana Press
  • Harrison NJ, Barbaric I & Andrews PW (2010) , Stem Cells (pp. 1-22). WORLD SCIENTIFIC
  • Harrison NJ, Barbaric I & Andrews PW (2010) , Stem Cells: From Bench to Bedside, Second Edition (pp. 1-22).
  • Addis RC, Amit M, Andrews PW, Anversa P, Atala A, Axelman J, Bang AG, Barrandon Y, Bauer SR, Becker D , Benvenisty N et al (2009) , Essentials of Stem Cell Biology (pp. ix-xiii). Elsevier
  • Tonge PD & Andrews PW (2007) , Human Cell Culture (pp. 235-253). Springer Netherlands
  • Andrews PW & Gokhale PJ (2007) , Principles of Regenerative Medicine (pp. 136-147).
  • ANDREWS P (2006) , Cell Biology (pp. 183-190). Elsevier
  • Matin MM, Bahrami A, Liew D & Andrews PW (2005) , Stem Cells (pp. 38-54). WORLD SCIENTIFIC
  • Johnson PA & Andrews PW (2004) , Handbook of Stem Cells (pp. 111-118).
  • Draper JS & Andrews PW (2004) , Handbook of Stem Cells (pp. 565-571).
  • Draper JS & Andrews PW (2004) , Handbook of Stem Cells (pp. 565-571). Elsevier
  • Johnson PA & Andrews PW (2004) , Handbook of Stem Cells (pp. 111-118). Elsevier

Conference proceedings

  • Frith TJR, McCann C, Gogolou A, Thapar N, Tsakiridis A, Burns A & Andrews PW (2019) Transplantation of hPSC derived enteric neural progenitors as a basis to derive a preclinical cell therapy for Hirschsprung's disease. HUMAN GENE THERAPY, Vol. 30(8) (pp A17-A17)
  • Halliwell JA, Barbaric I & Andrews PW (2019) Mechanisms that lead to genetic instability in human pluripotent stem cells. HUMAN GENE THERAPY, Vol. 30(8) (pp A18-A19)
  • Biga V, Alves Coelho OM, Gokhale PJ, Mason JE, Mendes EMAM, Andrews PW & Coca D (2017) . Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), Vol. 10477 LNBI (pp 93-106)
  • Ahmed MI, Harrison NJ, Mardaryev AN, Fessing MY, Poterlowicz K, Andrews PW & Botchkarev VA (2013) Genome organizer Satb1 regulates differentiation-associated silencing of the Nanog locus by modulating its nuclear positioning in human embryonic stem cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, Vol. 133 (pp S246-S246)
  • Ahmed MI, Harrison NJ, Poterlowicz K, Mardaryev AN, Fessing MY, Andrews PW & Botchkarev VA (2012) Differentiation-associated Silencing of the Nanog Locus is Accompanied by Changes in its Nuclear Positioning in Human Embryonic Stem Cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, Vol. 132 (pp S105-S105)
  • Ahmed MI, Harrison NJ, Mardaryev A, Fessing MY, Poterlowicz K, Andrews PW & Botchkarev VA (2012) Differentiation-associated silencing of the Nanog locus is accompanied by changes in its nuclear positioning in human embryonic stem cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, Vol. 132 (pp S141-S141)
  • Adamah D, Gokhale PJ, Walsh J & Andrews PW (2002) A notch-related gene located on the long arm of human chromosome 12. GERM CELL TUMOURS V (pp 30-31)
  • Gokhale PJ, Eastwood D, Walsh J & Andrews PW (1998) The possible role of Notch genes in germ cell tumour development and progression. GERM CELL TUMOURS IV (pp 69-71)
  • Gels ME, Marrink J, Visser P, Sleijfer DT, Droste JHJ, Hoekstra HJ, Andrews PW & Koops HS (1997) Importance of a new tumor marker TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors. ANNALS OF SURGICAL ONCOLOGY, Vol. 4(4) (pp 321-327)
  • ANDREWS PW, MAVILIO F, ZAPPAVIGNA V & SAMPATH TK (1994) GROWTH-INHIBITION AND DIFFERENTIATION OF A HUMAN EMBRYONAL CARCINOMA (EC) CELL-LINE BY OSTEOGENIC PROTEIN-1 (OP-1). GERM CELL TUMOURS III, Vol. 91 (pp 151-152)

Preprints

  • Jevans B, Cooper F, Peruzza L, Perin S, Li S, McAteer T, De Coppi P, Andrews PW, Tsakiridis A & McCann CJ (2025) , Cold Spring Harbor Laboratory.
  • Jevans B, Cooper F, Fatieieva Y, Gogolou A, Kang Y-N, Restuadi R, Berghe PV, Adameyko I, Thapar N, Andrews PW , Coppi PD et al (2023) , Cold Spring Harbor Laboratory.
  • Saldana-Guerrero IM, Montano-Gutierrez LF, Hafemeister C, Stavish D, Shaw LE, Fetahu IS, Wenninger-Weinzierl A, Sturtzel C, Souilhol C, Tarelli S , Shoeb MR et al (2022) , Cold Spring Harbor Laboratory.
  • Halliwell JA, Baker D, Judge K, Quail MA, Oliver K, Betteridge E, Skelton J, Andrews PW & Barbaric I () , Cold Spring Harbor Laboratory.
  • Boisen IM, Nielsen JE, Kooij I, Kaludjerovic J, O’Shaughnessy PJ, Andrews PW, Ide N, Toft BG, Juul A, Smith LB , Norman RW et al () , Cold Spring Harbor Laboratory.
  • Wind M, Gogolou A, Manipur I, Granata I, Butler L, Andrews PW, Barbaric I, Ning K, Guarracino MR, Placzek M & Tsakiridis A () , Cold Spring Harbor Laboratory.
  • Halliwell JA, Frith TJR, Laing O, Price CJ, Bower OJ, Stavish D, Gokhale PJ, Hewitt Z, El-Khamisy SF, Barbaric I & Andrews PW () , Cold Spring Harbor Laboratory.
  • Frith TJR, Gogolou A, Hackland JOS, Barbaric I, Thapar N, Burns AJ, Andrews PW, Tsakiridis A & McCann CJ () .
  • Stavish D, Böiers C, Price C, Frith TJR, Halliwell J, Barbaric I, Brown J, Carr J, James C, Andrews PW & Enver T () , Cold Spring Harbor Laboratory.
Grants
  • European Union
  • UK Regenerative Medicine
  • MRC/International Stem Cell Forum
Teaching activities

Undergraduate and postgraduate taught modules

Level 3:

  • BMS382 Stem Cell Biology
  • BMS349 Extended Library Project

Masters (MSc):

  • BMS6056 Stem Cell Biology
Professional activities and memberships
  • Chairman, Department of Biomedical Science, 1995-2003.
  • Co-founder and Director, Axordia Ltd., A University Spin-out Company (now a subsidiary of Pfizer)
  • Director, Centre for Stem Cell Biology (CSCB)
  • Co-ordinator of ESTOOLS, a European FP6 Integrated Project (2006–2010)

Current external activities

  • Editorial Boards:  Journal of. Anatomy, Stem Cells, Regenerative Medicine, Handbook of Stem Cells, Stem Cell Research, Stem Cells and Development.
  • Co-ordinator of the International Stem Cell Initiative 2003 – present

Past

  • 2014 Director, Pluripotent Stem Cell Platform (a Hub under the UKRMP) 2014 - 2018
  • 2008 Member MRC Translational Stem Cell Research Panel (July 2008 – 2013)
  • 2007 Member SAB for Stem Cells for Safer Medicines (SC4SM), a PPP company established by the DTI and the ABPI to develop applications of human ES cells in predictive toxicology (2007 – 2011).
  • 2010 SAB Bioprocessing Technology Institute, Biopolis, Singapore, 2010 - 2011.
  • 2009 Participant in MRC delegations to California (Jan 2009); to China (May 2009)
  • 2009 Member of INSERM review committee for INSERM Unit, I-Stem, Evry, Paris. Jan 2009
  • 2008 Invited Participant in UK FCO sponsored ‘Road Show on UK Human ES cell research, California, Feb 2008
  • 2007 Review panel for Canadian Stem Cell Network (Sept 2007).
  • 2007 Expert Review Panel for 21st Century Centre of Excellence Program, Kyoto University (Japan, June 2007)
  • 2006 Member Steering Committee for UK Toxicology Initiative July 2006 – 2007
  • 2006 Co-ordinated for MRC and CIRM a UK:California Stem Cell meeting, held in the UK Nov 2006.
  • 2006 Member, NIH National Stem Cell Bank, USA, 2006 - 2009
  • 2006 Elected Board Member, ISSCR, March 2006 to 2009
  • 2005 Member MRC Molecular Cell and Medicine Board April 2005- April 2010
  • 2005 Represented MRC in meeting with California Institute Regenerative Medicine, San Francisco April 2005